Skip to main content
Idea 2 Impact

Idea 2 Impact

By Texas A&M University Innovation Partners

Ever wonder how people are able to shift their ideas that originate on paper into real-life inventions that changed the world? Who are these inventors? How are they able to transfer their ideas to impact the world? Join co-hosts Beth Deuermeyer and Jack Manhire on the Idea 2 Impact podcast, presented by Texas A&M University Innovation Partners, where we bring you the inside scoop on how faculty and other community members successfully translate their ideas into inventions, while also teaching, researching, and mentoring other faculty members and students.
Available on
Apple Podcasts Logo
Google Podcasts Logo
Overcast Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Currently playing episode

Ep. 5: Why it takes so long to approve vaccines and other drugs

Idea 2 ImpactSep 18, 2020

00:00
45:38
Copyrighted material in action: How commercialized material has enhanced education and healthcare

Copyrighted material in action: How commercialized material has enhanced education and healthcare

Jun 18, 202157:51
From research to commercialization: The use of federal funding to create real-world impact
Jun 04, 202136:07
Hashing out the future of cannabis commercialization: A deeper dive into research, labeling, and marketing in industry

Hashing out the future of cannabis commercialization: A deeper dive into research, labeling, and marketing in industry

In episode 2, Lance continues the conversation about IP in the cannabis industry. Jack and Beth highlight how Colarado, a state where cannabis is legal, utilizes the plant for innovation. The trio examines gene editing, FDA procedures, gut biology, and the more biological standpoint for examining cannabis. Lance explains the progression of university research and how that alongside celebrity endorsements and incorporating other industries has an impact on the market effect of cannabis. The conversation comes full circle, with Beth, Jack, and Lance discussing how commercial activity and research puts products in the hands of the people and how Innovation Partners can aid in grants, innovative leaders, and commercializing even the most taboo of innovations.

May 21, 202147:35
A budding area of innovation: A look at the intellectual property Landscape in the Cannabis industry

A budding area of innovation: A look at the intellectual property Landscape in the Cannabis industry

Beth and Jack speak with Lance Anderson, an IP attorney at Dickson and Wright LLP. In this episode, we talk about Lance ended up in the IP world with a background in agriculture, how his college's tech transfer office helped him, and his time as a law student. This episode dives into how advancing opportunities require more than just a good idea and how commercialization is required for the biggest impact in today's world. Additionally, Anderson discusses his work as an IP attorney with a focus on patenting and commercializing for marijuana related inventions and research. We discuss the cannabis industry, legalization, and how intellectual property works in the cannabi industry. From black market growers to the process works within states that have legalized cannabis to the two prong system that defines the industry, Anderson dives into the IP and commercialization of cannabis inventions around the U.S.

May 07, 202152:41
Molding Minds: STELLA's success in education through commercialization and patenting

Molding Minds: STELLA's success in education through commercialization and patenting

In episode 2, Beth and Jack continue their conversation with Dr. Etchells and Dr. Lara-Alecio. They dive into the STELLA program, covering it's success as a dual-literacy program for young children and how it works so effectively. Learn more about how STELLA truly went from idea to impact on this episode.

Apr 23, 202156:58
Education and Entrepreneurship: Lessons Learned from Private Industry Experience

Education and Entrepreneurship: Lessons Learned from Private Industry Experience

In this episode, Jack and Beth talk with Dr. Matthew Etchells and Dr. Rafael Lara-Alecio about the cross roads of education and commercialization. They discuss STELLA, a program that was developed by CRDLLA and which Innovation Partners helped to license with Frog Street LLC. Dr. Lara-Alecio and Dr. Etchells share how their backgrounds in private industry have shaped their perspectives on research and commercialization, and how commercializing inventions leads to a bigger impact. This episode dives into the impact of education and how it can shape ideas and reach the greatest audience through commercialization.


For more information on CRDLLA, please visit https://crdlla.tamu.edu


Apr 09, 202148:05
Innovation and Policy: How the two work together

Innovation and Policy: How the two work together

In episode 2, our conversation with Anton Howes continues. We dive further into the type of thinking it takes to be an inventor and look at the inventors and innovative thinkers that helped start, and ultimately, led to the Industrial Revolution. We explore policy and the policy recommendations that might come out of Howes' work.

Mar 26, 202158:14
Early Inventors and Historical Surges of Innovation
Mar 12, 202140:14
Moving your invention along: The importance of seeking guidance from your tech transfer office

Moving your invention along: The importance of seeking guidance from your tech transfer office

In part 2 of our conversation with Michael Sharer, we disucss Texas A&M Innovation Partner's Translational Investment Fund (TIF), market analysis, and resources avaliable for inventors at different stages. Dr. Sharer explains how TIF offers early stage technologies an opportunity to advance in the market, and further explains the importance of tech transfer offices for the advancement of university technology.

For more information on the Translational Investment Fund, or Texas A&M University Innovation Partners, please visit www.tamuip.tamu.edu.

Feb 26, 202156:30
Learning from Failure: An Entrepreneur's Perspective

Learning from Failure: An Entrepreneur's Perspective

In this episode, we delve into the importance of failure in entrepreneurship and how we can learn from it.  Associate Vice President for Commercialization, Michael “Mike” Sharer discusses the importance of entrepreneurial training for graduate students and post-doctoral researchers. We start out with discussing Mike’s experience in industry prior to moving to Texas, and how he plans to help Innovation Partners continue to grow here at Texas A&M. Mike shares where his interest in innovation sparked from, the importance of researchers knowing about intellectual property, and the multi-faceted knowledge that gives you a head start in commercialization of inventions.


For more information on technology transfer and commercialization at Texas A&M University, please visit www.tamuip.tamu.edu.

Feb 12, 202145:02
 'We're here to help': Advice for university inventors working with technology transfer offices

'We're here to help': Advice for university inventors working with technology transfer offices

In part 2 of our conversation with Dr. Wei Wan, we discuss specifically the technology transfer process here at Texas A&M. Dr. Wan gives advice to inventors in different stages, from graduate students to seasoned tenured faculty members. She argues for why faculty should be interested in commercialization regardless of whether they are interested in getting their ideas to the market, and discusses how Innovation Partners or other technology transfer offices can help with the process to make it seem less daunting and overwhelming. If you're curious about how licensing managers move ideas from disclosures to the marketplace, you won't want to miss this episode! Head to www.tamuip.edu to learn more about Innovation Partners. 

Jan 29, 202158:22
The Road Less Traveled: From Researcher to Licensing Manager

The Road Less Traveled: From Researcher to Licensing Manager

With over 20 years of experience as a university researcher and professor, Wei Wan’s journey to technology transfer and patenting is filled with change, challenge, and passion. In this episode, Wei Wan discusses her background in biology and how her research ultimately led her to taking the patent bar and becoming a patent agent. Now a senior licensing manager at Texas A&M Innovation Partners, Wan shares not only how she ended up where she is, but how Innovation Partners can help other inventors and entrepreneurs patent their technologies.

Jan 20, 202148:36
Dr. Larry Griffing: How Herbicides Can Help the Environment

Dr. Larry Griffing: How Herbicides Can Help the Environment

Dr. Larry Griffing continues to find new technologies to improve his environment through his research. In this episode, we learn about his i-Corps program and his Innovation X Grant that teaches students about herbicides and biology as well as commercialization and the process that goes behind it. 


For more information on Innovation[X], please visit https://innovation.tamu.edu/collaborate/innovation-x/

Jan 06, 202156:04
From Robert Hook to Endoplasmic Reticulum: Science, Research, and Innovation
Dec 11, 202036:07
Giving Back: Making An Impact Through Research

Giving Back: Making An Impact Through Research

Dr.Virender Sharma is dedicated to saving lives and helping others, so his approach to his technology is done selflessly. Dr. Sharma works as a consultant for the business that markets his technology while also continuing to do his work at Texas A&M. In this episode, he discusses why it is important to get your research out there, and he doesn't just mean through publications. Sharma, the “Real Iron Man” represents public health well, working hard to help those in need, especially during a time of great need. To learn more about the work Sharma does, listen to Idea 2 Impact or visit https://public-health.tamu.edu/directory/sharma.html

Nov 30, 202045:37
The Real Iron Man: Clean Water with Ferrate
Nov 16, 202044:44
Ep. 8: Perfecting Your Entrepreneurial Pitch

Ep. 8: Perfecting Your Entrepreneurial Pitch

Find out more about the Texas New Ventures Competition at http://www.TexasNVC.org 

Chris Scotti is a serial entrepreneur and long-time supporter of the innovation ecosystem in Texas. He has over 25 years of experience founding, growing and coaching emerging technology companies through relationships with private businesses and economic development organizations, as well as government and higher education institutions. Scotti’s biggest strength is the ability to play in both the technical and business worlds, and act as a connector between the two.  

Scotti is a frequent speaker to students and faculty at Texas A&M University about entrepreneurship and raising capital. He also is a regular judge, panelist, and mentor in entrepreneur and emerging technology focused state and national events. Scotti has a history as both an elected official and entrepreneur, and is dedicated to helping coach companies and foster the entrepreneurial ecosystem in Aggieland and Texas as a whole.

Oct 30, 202040:59
The Making of an Entrepreneur

The Making of an Entrepreneur

Chris Scotti is a serial entrepreneur and long-time supporter of the innovation ecosystem in Texas. He has over 25 years of experience founding, growing and coaching emerging technology companies through relationships with private businesses and economic development organizations, as well as government and higher education institutions. Scotti’s biggest strength is the ability to play in both the technical and business worlds, and act as a connector between the two.

Scotti is a frequent speaker to students and faculty at Texas A&M University about entrepreneurship and raising capital. He also is a regular judge, panelist, and mentor in entrepreneur and emerging technology focused state and national events. Scotti has a history as both an elected official and entrepreneur, and is dedicated to helping coach companies and foster the entrepreneurial ecosystem in Aggieland and Texas as a whole.

Oct 16, 202039:33
Ep. 6: The Orphan Disease Strategy for FDA Approval

Ep. 6: The Orphan Disease Strategy for FDA Approval

#vaccine #orphandisease #orphandrug #FDAapproval  

Part 2 of 2. You can find Part 1 here: https://anchor.fm/idea-to-impact/episodes/Ep--5-Why-it-takes-so-long-to-approve-vaccines-and-other-drugs-ejpcmj

 Dr. Thomas Kent who is the Robert H. Welch Chair Professor at Texas A&M’s Institute of Biosciences and Technology, or IBT as we call it, down in Houston, is our guest this afternoon. You will find out as you listen today that Dr. Kent’s story is unique to his area--he is a neurologist, specifically vascular neurology, as well as a teacher and researcher. Because he is working with drugs that will actually be used or injected into the human, the idea to impact journey can be a long one.  In today's episode we continue to discuss Dr. Kent's work, and the complexities of getting a drug onto the shelf in your pharmacy.

Dr. Kent’s basic science research is exploring the mechanisms by which stroke and neurodegeneration cause their injuries and create new therapies employing carbon-based nanomaterials.  His laboratory has a major focus on commercialization with several patents granted and pending.  This nanomedicine program has garnered nearly $7 million in federal funding and he is actively involved with private investment toward commercialization. Dr. Kent’s NIH-funded clinical research involves precision medicine to identify differences in the response to stroke therapies based on race and sex in collaboration with Morehouse School of Medicine.  This research is important because of the high burden of stroke in the African American community and the “stroke belt” of the Southern US. He is also funded by the State of Texas Lone Star Stroke consortium, a network of the major Texas academic Neurology departments, to study ways of providing better access to stroke prevention in underserved, rural and resource poor urban regions.

Oct 02, 202041:04
Ep. 5: Why it takes so long to approve vaccines and other drugs

Ep. 5: Why it takes so long to approve vaccines and other drugs

You will find out as you listen today that Dr. Thomas Kent’s story is unique to his area--he is a neurologist, specifically vascular neurology, as well as a teacher and researcher. BEcause he is working with drugs that will actually be used or injected into the human, the idea to impact journey can be a long one.

Thomas Kent, MD, is the Robert H. Welch Chair Professor at Texas A&M’s Institute of Biosciences and Technology (IBT). Dr. Kent’s basic science research is exploring the mechanisms by which stroke and neurodegeneration cause their injuries and create new therapies employing carbon-based nanomaterials.  His laboratory has a major focus on commercialization with several patents granted and pending.  This nanomedicine program has garnered nearly $7 million in federal funding and he is actively involved with private investment toward commercialization. Dr. Kent’s NIH-funded clinical research involves precision medicine to identify differences in the response to stroke therapies based on race and sex in collaboration with Morehouse School of Medicine.  This research is important because of the high burden of stroke in the African American community and the “stroke belt” of the Southern US. He is also funded by the State of Texas Lone Star Stroke consortium, a network of the major Texas academic Neurology departments, to study ways of providing better access to stroke prevention in underserved, rural and resource poor urban regions.

Sep 18, 202045:38
Episode 004- From Crossfit to Oil and Gas: Let's Talk Business
Sep 04, 202053:36
Episode 003: We Respect Failure-Omar Hakim

Episode 003: We Respect Failure-Omar Hakim

Who else wants to know what investors are really looking for in the perfect pitch?  Welcome to Idea2Impact, the show where you will hear from inventors and entrepreneurs who have some amazing stories of how they have taken their research and ideas from pencil and paper all the way to market.   On this episode, Drs. Beth Deuermeyer and Jack Manhire talk with Prof. Omar Hakim, who is a professor of practice in entrepreneurship and technology at Texas A&M University. If you want to talk business, companies, and entrepreneurship, from Crossfit all the way to oil and gas, Omar is the person to talk to.

Aug 21, 202048:19
Episode 002 - Dr. Ashlee Jahnke
Aug 06, 202001:10:31
Episode 001: How to be an Inventor *AND* Seek Tenure

Episode 001: How to be an Inventor *AND* Seek Tenure

On the inaugural episode of the Idea 2 Impact podcast, we sit down with Dr. Mark Benden, Department Head and Associate Professor in the Department of Environmental and Occupational Health, as well as Associate Professor in the Department of Industrial & Systems Engineering, and Director of the Ergonomics Center at the School of Public Health.⁣ ⁣ ⁣


Mark starts by sharing how he found his way to Texas A&M and then dives into how he has enjoyed life as a husband, and father, now grandfather, while also becoming one of A&M’s most successful inventors and lovable mentors. ⁣ ⁣ ⁣


This wasn’t always easy, especially as a junior faculty member, but with a lot of determination and effort in the beginning, his research has now been used in setting industry standards, and he also holds 21 US patents and several others that are pending, all while teaching, researching, and mentoring students and faculty alike.⁣ ⁣ ⁣ ⁣


For more information on Dr. Benden's work, visit https://health.tamu.edu/experts/mark-benden.html⁣ ⁣ ⁣


Want more? Contact Dr. Beth Deuermeyer by visiting www.TAMUIP.tamu.edu or by email at tamuip@tamu.edu

Jul 28, 202001:10:17
Idea 2 Impact Trailer

Idea 2 Impact Trailer

Ever wonder how people are able to shift their ideas that originate on paper into real-life inventions that changed the world? Who are these inventors? How are they able to transfer their ideas to impact the world? Join co-hosts Beth Deuermeyer and Jack Manhire on the Idea 2 Impact podcast, presented by Texas A&M University Innovation Partners, where we bring you the inside scoop on how faculty and other community members successfully translate their ideas into inventions, while also teaching, researching, and mentoring other faculty members and students. 

Jul 27, 202001:25